Venture Capital & Emerging Growth
For entrepreneurs and founders navigating a competitive market to identify, negotiate for, and structure capital, it is crucial to partner with a firm that can guide you through every stage of growth. For those on the other side of the table, whether you’re an investor focused on comprehensive due diligence in complex industries or a multinational enterprise seeking to leverage the strategic value of its investment dollar, you need a team of venture capital lawyers who can help you identify and maximize opportunities. At McDermott Will & Schulte, we tackle your business objectives from a holistic perspective, having advised both innovators and investors in various industries on the full spectrum of domestic and international investment transactions.
With decades of experience supporting companies throughout the business life cycle – from formation to sale or initial public offering – we’ll work closely with you and help you overcome any challenge that arises. We operate across practices and industries to provide a full slate of corporate and transactional advice. We also have a strong understanding of the corporate venture capital ecosystem, current market trends, and potential issues you might face in the growth equity and innovation space. To best serve client needs, we draw on our history representing venture and private equity funds and venture-backed companies in acquisitions, financing transactions, the negotiation of credit facilities, corporate governance, employment, and equity compensation matters. In any sector, from digital health to insurance and fintech, we have the deep industry knowledge and capability to perform effective due diligence; assess company strategy; and assist with immediate transactions, post-closing integrations, and long-term strategic planning.
As a responsive, fast-moving team, our venture capital lawyers can also help you resolve day-to-day legal issues by delivering business-driven, sophisticated advice to advance your objectives. When you partner with us, we’ll provide an unmatched ability to absorb complex information and apply our knowledge of the venture and growth equity market to quickly deliver tailored solutions.
Health
Company representation
- Represented Apostrophe, a teledermatology platform, in connection with its sale to Hims & Hers Health, Inc.
- Represented Array Behavioral Care, a virtual psychiatry and therapy practice, in its latest equity round led by CVS Health Corporation
- Represented Brave Health, the largest virtual mental health provider and engagement platform focused on serving Medicaid populations, in its Series C funding
- Represented CleanSlate Centers, Inc. in its Series B preferred stock financing led by Apple Tree Partners IV, L.P. CleanSlate operates drug addiction treatment and rehabilitation centers throughout Massachusetts, Pennsylvania, and Indiana
- Represented Clinify Health Inc., a digital health company, in its initial Series Seed round
- Represented Codoxo, Inc., an artificial-intelligence (AI)-assisted platform designed to accelerate the identification of fraud, waste, and abuse in healthcare plans, in its Series B financing
- Represented Curation Health, LLC, a portfolio company of WindRose Health Investors, LLC, in its Series A financing round with Deerfield Management Company, LP
- Represented DropStat, Inc., a nurse scheduling solution, in multiple follow-on rounds
- Represented Equum Medical in its growth equity investment from The Heritage Group
- Represented Eurazeo’s Nov Santé Actions Non Cotées Fund in its first growth equity deal in Kinvent Physio, which amounted to €16 million
- Represented Five Arrows Growth Capital in a new round of financing for Padoa, which amounted to €80 million
- Represented Florence Healthcare, Inc. in its Series C financing
- Represented Gradient Denervation Technologies, a medical device company developing a minimally invasive solution for the treatment of heart failure in patients with pulmonary hypertension, in its Series A financing led by Sabadell Asabys II and Sofinnova Partners
- Represented Maven Clinic, the largest virtual clinic for women’s and family health, in its Series E funding round led by General Catalyst
- Represented Pediatrix Medical Group, Inc. (formerly, Mednax), a Florida-based healthcare organization, in its Series B investment in BraveCare, Inc., a pediatric healthcare organization
- Represented Nightingale Veterinary, a veterinary medicine platform, in multiple financing transactions
- Represented PreciseDx, Inc., a healthcare services provider delivering patient-specific insights through AI-driven pathology tests and labs, in its Series B financing led by Eventide, Inc.
- Represented Summus Global, a company that connects individuals, families, and doctors with the right specialist, in multiple financing transactions
- Represented White Plains Hospital in multiple investments
Fund representation
- Represented BIP Ventures in financing multiple investments
- Represented CVS Health Ventures, a corporate venture capital fund, in connection with its investment in Carbon Health, a primary and urgent care company
- Represented Deerfield Management Company and its affiliated funds as the lead investors in their Series A preferred stock financing of Hometeam Technologies, Inc., an emerging healthcare technology company that leverages its proprietary platform to enhance in-home caregiver services
- Represented Deerfield Management Company in its Series C investment round in Presidio Medical
- Represented Enhanced Healthcare Partners in its Series B and C capital raises in Vytalize Health, Inc., a value-based care platform providing smart technology and a virtual clinic that enables independent physicians and practices to succeed in value-based care arrangements
- Represented General Atlantic in its Series B funding in Javara, a leading integrated research organization and a pioneer of clinical research as a care option
- Represented General Atlantic as healthcare regulatory counsel in its Series D financing of Vida Health, a virtual chronic mental and physical care platform
- Represented General Atlantic as healthcare regulatory counsel in its Series D financing of Doctor on Demand, Inc., a leading virtual healthcare provider
- Represented McKesson Ventures in multiple investments, including in IVXpress, Inc. and Shyft
- Represented Merck Global Health Innovation Fund, LLC in multiple investments, including in Delfi Diagnostics, Octave, M2GEN, and PreciseDx
- Represented Morgan Health in its Series C-3 investment in Kindbody, Inc.
- Represented Morgan Health in its Series D-2 investment in Paulus Holdings Limited (d/b/a LetsGetChecked)
- Represented Morgan Health in its Series B-1 investment in Centivo
- Represented The Carlyle Group in its investment round in Grand Rounds, a leader in healthcare quality and clinical navigation
- Represented Triatomic Capital in multiple investments, including in Chemify, Betteromics, Elegen, and d-Matrix
- Represented Warburg Pincus LLC as regulatory counsel in connection with its Series C leading investment in Aetion
Technology and SaaS
Company representation
- Represented Ardian, in its acquisition of a minority stake in Taxually
- Represented Cove Tool, Inc., a web-based software for analyzing, drawing, engineering, and connecting data for building design and construction, in its Series B financing
- Represented ClassPass, a premier fitness membership, in each of its equity financings, including its $285 million Series E financing; its acquisitions of Clickypass, fitmob, FitnessCollection, GuavaPass, and MuvPass; and its merger with Mindbody, Inc. and the companion $500 million equity financing for the combined company*
- Represented CyEx in its acquisition of Simpluris, the industry leader in class action settlement administration for the public sector across various verticals
- Represented a leading cleantech solutions company in its late-stage financing rounds and multiple acquisitions*
- Represented Maximum Effort Marketing in its sale to performance television platform MNTN*
- Represented several high-profile talent and other high-profile individual investors in their venture investments
- Represented Olympus Pines in various financing and transactional matters
- Represented Optios, Inc. in its initial equity financing round
- Represented Texture in its financing rounds*
- Represented The Hershey Company in various growth company investments*
- Represented Riot Security in its Series A financing round led by Base10, which amounted to $14 million
- Represented 9dcc in its seed financing*
Fund representation
- Represented BIP Ventures in multiple investments
- Represented Hoxton Ventures LLP, an early-stage venture capital firm, as lead investor in its Series Seed fundraising round for Poetics AI Limited, a provider of AI-powered solutions to the creative sector to accelerate and improve generation and analysis of long-form text through software as a service (SaaS)
- Represented Knoll Ventures in multiple investments
- Represented Motorola Solutions, Inc. in multiple corporate venture capital investments in various software and technology companies
- Represented SineWave Ventures in the formation of its venture funds and in all of its 30+ investments and portfolio exits
- Represented Viking Global Investors in multiple investments, including in Arctic Wolf, Clip, and Affinivax, Inc.
Life Sciences and Biotech
Company representation
- Represented Aboleris Pharma, a Belgian biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, in its Series A financing
- Represented Antabio in raising Series B funding for the development of new treatments for antibiotic-resistant infections
- Represented BioSpring in its investment in Abzena, a leading global partnership research organization providing integrated discovery, development, and manufacturing of biologics and antibody drug conjugates
- Represented Cleveland Clinic, a nonprofit multispecialty academic medical center, in its Series B equity financing of Centerline Biomedical, Inc., a private medical technology company that develops surgical navigation systems
- Represented Cordis in multiple investments, including in Portola, Ladera, Medical, Echo Medical, Venice Medical, Tahoe Medical, IV-X Health, and Convext Medical
- Represented Corteria Pharmaceuticals, a biopharmaceutical company specializing in the development of transformative therapies for unaddressed heart failure subpopulations, in its €65 million Series A round transaction
- Represented DioGenX, a biotech company specializing in the regeneration of insulin-producing beta cells for the treatment of diabetes, in its Series A financing round
- Represented ImmuneSensor Therapeutics, Inc., a clinical-stage biotechnology company, in connection with an investment by Yunnan Baiyao Group Co., Ltd. for Series A preferred stock in ImmuneSensor
- Represented Kythera Labs, Inc., a data analytics provider in the pharma services space, in a follow-on investment
- Represented Merck KGaA, Darmstadt, Germany, a leading science and technology company, in its venture-capital-style investment in High Line Bio, Inc. (HLB)
- Represented Novo Holdings A/S, an investment and holdings company, in its Series C investment in Amolyt Pharma, a global company that develops therapeutic peptides for rare endocrine and related diseases, led by Sofinnova Partners
- Represented TRiCares GmbH, a pioneer in the minimally invasive treatment of tricuspid regurgitation, in its €47 million financing round following the closing of its Series C financing round
- Represented Toku Inc., a leader in applying AI-powered diagnostic and screening tools to retinal imaging, in its Series A preferred financing round
Fund representation
- Represented Advent Life Sciences, a UK-based venture capital fund, in its investment in the Series C financing of Moximed, Inc., a California-based developer of shock absorbing knee implants for osteoarthritis
- Represented Affinity Partners, LLC in its Series A investment in Altesa BioSciences, Inc., a clinical-stage biopharmaceutical company
- Represented Aisling Capital in multiple investments, including in TheRas,Inc., CalciMedica, Bicara Therapeutics, Mindful Health Solutions, and Treeline Biosciences
- Represented Ajax Health in multiple investments, including in Cortex, Maverix Medical, LLC, and Treeline Biosciences
- Represented Amzak Health in multiple investments, including in KOKO Medical
- Represented Deerfield Management in multiple investments, including in Adaptive Phage Therapeutics, Adela, Pleno Inc., Beartooth, Medical Microinstruments, Inc., and Presidio Medical, Inc.
- Represented General Atlantic in multiple investments, including in Javara, Motif FoodWorks and Ultima Genomics, Inc.
- Represented Merck Global Health Innovation Fund in connection with various life sciences investments
- Represented Norwest Venture Partners, a California-based venture capital firm, as an investor in the closing of its Series E investment round in Elligo Health Research, Inc., a clinical trial technology company
- Represented Novartis Venture Fund, Lilly Ventures, and Enso Ventures in their investment in Cavion, Inc.
- Represented Novo Holdings in its Series C financing of Amolyt Pharma
- Represented Sofinnova Partners in its investments in Cure51, LifeX, and Hitachi, Ltd.
- Represented The Clermont Group, a Singapore-based international business group, as the lead investor in its Series A investment round in PostEra, a Boston-based biotechnology company
Insurtech
Company representation
- Represented Boost Insurance in its formation and various transactional and regulatory matters*
- Represented CHAMP Titles in its $18 million Series C funding led by Point72 Ventures
- Represented Pathpoint, Inc., a digital insurance wholesale brokerage service provider, in its capital raise with investor Caffeinated Capital
- Represented Rhino Labs, Inc. in its formation and Series Seed preferred stock initial capital raise of $1.5 million with a prominent venture capital firm*
- Represented Tarmika, Inc., a commercial lines rating solution for small business insurance, in its acquisition by Applied Systems, a global provider of cloud-based software that powers the business of insurance
- Represented weSure Digital Insurance Services, Inc. in its investments from Technology Insurance Company Inc.
Fund representation
- Represented a New-York-based fund as lead investor in its Series C financing and subsequent follow-on round for an insurtech company whose nationally available products integrate the procurement of homeowner’s insurance directly into the home-buying process
- Represented a Swiss family office in its Series B investment in a digital insurance producer that empowers consumers to buy home and auto insurance on their smartphones, tablets, or computers in minutes
- Represented Gigafund, a venture capital firm, in its follow-on investment in Sana Benefits’ $20 million Series A extension funding
- Represented IA Capital Group in certain startup venture investments
- Represented Infinity VC in its Series A investment in Sensible Weather
- Represented a venture capital firm in its investment in a tech-enabled managing general agent specializing in wildfire-related risks
- Represented Volery Capital Partners as lead investor in its Series B funding of Buckle, a digital financial services company
- Represented USAA in its acquisition of Noblr, Inc., a usage-based insurance business
FinTech
Company representation
- Represented Trustpair in its €20 million Series B financing round led by Tikehau Ace Capital and Tikehau’s historical shareholders, including Breega and Axeleo Capital
Fund representation
- Represented HSBC Financial Technology Venture Capital Fund in its cross-border convertible note investment in BetterTradeOff Pte Ltd., a Singapore-based fintech company
- Represented Multicoin Capital, a thesis-driven investment firm that invests in cryptocurrencies, tokens, and blockchain companies, in the formation of Venture Fund III
- Represented WestCap in leading a $1 billion funding round for New York Digital Investment Group LLC, a top Bitcoin company. This funding will value the company at more than $7 billion
*Matter handled prior to joining the firm.
Deal announcement, Press release
Deal announcement, Press release
Droit des Sociétés et Transactions
L’activité corporate d’une entreprise est au cœur de son succès. Qu’il s’agisse d’obtenir des capitaux, d’envisager une acquisition, d’assurer le maintien des activités courantes grâce à des contrats et accords solides, ou de surmonter des obstacles menaçant la survie de l’entreprise, il est primordial d’avoir une stratégie et de s’adjoindre les services d’un conseil juridique de confiance. Le département droit des sociétés de McDermott Will & Schulte dispose des compétences et ressources nécessaires pour répondre à la quasi-totalité des besoins de ses clients en la matière.
Notre équipe, qui justifie d’une grande expérience au service d’un large éventail d’entreprises à travers le monde (multinationales, entreprises familiales, sociétés non cotées…), se consacre à la résolution de problèmes complexes liés à leur activité. Nos compétences sont vastes. Elles nous permettent de répondre à l’ensemble des besoins courants de nos clients dans les cadre des opérations qu’ils réalisent, qu’il s’agisse de négocier une acquisition internationale ou un contrat de sous-traitance, de représenter un émetteur dans le cadre d’une offre au public de titres financiers, de négocier une convention de crédit à des conditions privilégiées pour le compte d’un emprunteur, ou de piloter une restructuration d’entreprise.
Au-delà des prestations classiques en droit des sociétés, McDermott Will & Schulte se distingue par sa capacité à innover, détecter les évolutions du marché et à élaborer des solutions juridiques d’avenir. Notre équipe spécialisée dans les investissements directs propose une gamme complète de services juridiques aux « family offices », afin de les accompagner dans l’investissement de leurs capitaux et de répondre aux besoins juridiques qui en découlent. Par ailleurs, notre équipe spécialisée dans les technologies, les transactions commerciales et l’outsourcing constitue une ressource hors pair pour accompagner nos clients dans leurs opérations ayant une composante technologique.
Nous sommes armés pour comprendre au mieux les défis auxquels nos clients doivent faire face et les secteurs dans lesquels ils évoluent. En tant que cabinet intégré, l’ensemble de nos avocats et de nos pratiques collaborent étroitement afin de fournir des conseils cohérents, inventifs et concrets. Notre connaissance fine du marché se décline dans des secteurs clés tels que la santé, les technologies, l’industrie, les matériaux, les biens de consommation, les produits professionnels, les produits alimentaires, les boissons, l’agro-industrie et les sciences de la vie. En couvrant l’ensemble des services juridiques, nous sommes à même d’apporter des conseils fiables aux entreprises et de répondre à l’ensemble de leurs besoins en droit des sociétés.
Disclaimer
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.